Alumis grosses $250 million with IPO and private placement

The private placement involved selling 2.5 million shares to a hedge fund-managed venture fund that invested in Alumis’ Series B and C rounds.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks